Span Divergent
26.90
-26.90(-100.00%)
Market Cap₹14.70 Cr
PE Ratio15.47
IndustryHealthcare
Company Performance:
1D-100.00%
1M-100.00%
6M-100.00%
1Y-100.00%
5Y-100.00%
View Company Insightsright
Latest news about Span Divergent
Span Divergent Reports Mixed Q1 Results: Standalone Profit Rises, Consolidated Loss Widens Aug 13, 2025
Span Divergent Limited reported improved standalone results but faced challenges in consolidated financials for Q1. Standalone profit after tax increased by 80.50% to Rs 41.67 crore, while total income decreased by 11.72% to Rs 64.93 crore. Consolidated loss after tax widened to Rs 17.01 crore. The company operates in cashew processing, tissue culture, and trading segments. Several subsidiaries are facing financial difficulties, with Aranya Agri Biotech LLP set to discontinue operations. Management remains optimistic about turning around struggling subsidiaries. Span Divergent maintains a strong financial position with minimal outstanding loans.